98%
921
2 minutes
20
Objective: To describe rates of dexamethasone use in the nonoperative management of malignant small bowel obstruction (mSBO) and their outcomes.
Background: mSBO is common in patients with advanced abdominal-pelvic cancers. Management includes prioritizing quality of life and avoiding surgical intervention when possible. The use of dexamethasone to restore bowel function is recommended in the National Comprehensive Cancer Network guidelines for mSBO. Yet, it is unknown how often dexamethasone is used for mSBO and whether results from nonresearch settings support its use.
Methods: This is a multicenter retrospective cohort study including unique admissions for mSBO from January 1, 2019 to December 31, 2021. Dexamethasone use and management outcomes were summarized with descriptive statistics and multiple logistic regression.
Results: Among 571 admissions (68% female, mean age 63 years, 85% history of abdominal surgery) that were eligible and initially nonoperative, 26% [95% confidence interval (CI) = 23%-30%] received dexamethasone treatment (69% female, mean age 62 years, 87% history of abdominal surgery). Dexamethasone use by site ranged from 13% to 52%. Among dexamethasone recipients, 13% (95% CI = 9%-20%) subsequently required nonelective surgery during the same admission and 4 dexamethasone-related safety-events were reported. Amongst 421 eligible admissions where dexamethasone was not used, 17% (95% CI = 14%-21%) required nonelective surgery. Overall, the unadjusted odds ratio (OR) for nonelective surgery with dexamethasone use compared to without its use was 0.7 (95% CI = 0.4-1.3). Using multiple logistic regression, OR after adjusting for site, age, sex, history of abdominal surgery, nasogastric tube, and Gastrografin use was 0.6 (95% CI = 0.3-1.1).
Conclusion: Dexamethasone was used in about 1 in 4 eligible mSBO admissions with high variability of use between tertiary academic centers. This multicenter retrospective cohort study suggested an association between dexamethasone use and lower rates of nonelective surgery, representing a potential opportunity for quality improvement.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191995 | PMC |
http://dx.doi.org/10.1097/AS9.0000000000000431 | DOI Listing |
Minerva Anestesiol
September 2025
Tropical Biome et Immunopathologie CNRS UMR-9017, INSERM U1019, Université de Guyane, Cayenne, French Guiana.
Background: Extended delays in non-elective surgeries have been associated with suboptimal outcomes. The SARS-CoV-2 pandemic forced healthcare systems to adapt their setups for unscheduled procedures, leading, in our institution, to a reorganization from a setup with two dedicated operating rooms (ORs) at a central facility without dedicated teams to a temporary one with both dedicated teams and ORs during lockdown phase. This study evaluates the impact of this transitions on the time to surgery considering unscheduled procedures.
View Article and Find Full Text PDFJ Opioid Manag
September 2025
King Edward Memorial Hospital, Subiaco, Perth, Western Australia. ORCID: https://orcid.org/0000-0003-2763-1163.
Aim: This study aims to assess the application of opioids for pain control in patients following a cesarean section (CS) at a tertiary referral obstetric hospital.
Methods: A retrospective cohort audit of CSs in September 2022 was conducted. Medical records were reviewed to capture patient demographics, opioid used, and discharge medications.
J Vasc Surg
August 2025
Vascular Surgery, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; Vascular Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna.
Introduction: Thoracoabdominal aortic aneurysms (TAAA) and juxta/pararenal abdominal aortic aneurysm reported as complex aortic aneurysms (cAAA), represent a technical and clinical challenge with endovascular repair embodying a preferred option for high risk patients. represent a technical and clinical challenge with endovascular repair embodying a preferred option for high risk patients. However, in case of non-elective presentation, both technical and clinical management and outcomes remain limited in Literature.
View Article and Find Full Text PDFAnn Thorac Surg
August 2025
Cardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Department of Surgery, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. Electronic address:
Background: Patients with end-stage renal disease (ESRD) are at increased risk for calcific aortic stenosis. Given limited data on the efficacy of transcatheter aortic valve replacement (TAVR) in this population, the present study examined acute mortality, complications, and 30-day nonelective readmissions in a national cohort of patients with ESRD.
Methods: The 2016-2021 National Readmissions Database was queried to identify all TAVR admissions (≥18years).
Perm J
August 2025
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Purpose: Insight about episode spending after elective procedures has driven interest in bundling reimbursement for surgical procedures. However, little is known about episode spending for health systems (payments) and patients (out-of-pocket [OOP] expenses) after unplanned, nonelective procedures such as hand trauma.
Methods: The authors used 2019-2022 national claims to conduct a cohort study of patients undergoing flexor tendon repair, open reduction internal fixation (ORIF) of a distal radius fracture, and replantation/revascularization.